Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Stelara
Pharma
AbbVie's Skyrizi continues booming growth trajectory
As Humira continues its sales free fall, newer Skyrizi proved a worthy successor over the first quarter with nearly matching sales.
Zoey Becker
Apr 26, 2024 12:06pm
Biocon Biologics gears up to challenge Stelara in the US
Feb 29, 2024 11:40am
Alvotech plots upcoming overseas Stelara biosim launches
Feb 16, 2024 7:20am
J&J's pharma business churns out growth ahead of Stelara cliff
Jan 23, 2024 11:31am
J&J expects 25 blockbuster drugs to drive future sales growth
Dec 5, 2023 4:42pm
J&J, Samsung Bioepis ink Stelara biosimilar settlement
Nov 30, 2023 4:48pm